Roche getting under the skin of biosimilar competition
Subcutaneous versions of its biologic blockbusters - including Mabthera and Herceptin - will help protect against biosimilar competition, says Roche.
Archives for July 24, 2016
Bioclinica acquires clinical research company
The acquisition of Compass Research expands Bioclinica’s access to several specialized populations with neurodegenerative disorders and other diseases.
Recipharm: Q2 rev up on M&As, higher demand and anti-radiation med
Acquisitions, higher demand for sterile liquid processing and a surge in Thyrosafe orders helped Recipharm offset pricing pressure in Portugal and lower UK sales in Q2.
Quintiles: continuous glucose monitoring to speed drug development
A recent FDA Advisory Committee vote could allow researchers to use continuous glucose monitoring (CGM) systems in place of traditional methods, providing “a myriad of customized data,” says Quintiles.
Medisafe launches commercial offering for pharma
Medisafe is launching Medisafe for Pharma after completing several pilots over the past year and a half - one of several new applications that have emerged as the industry focuses on patient centricity.
Micro Labs completes repeat studies and predicts drugs will be back on the market in autumn
Sandoz repeats tests and Teva pulls malaria pill as EMA calls for suspension of Semler trialled drugs
Sandoz is repeating bioequivalence studies and Teva is withdrawing an antimalarial after the EMA recommended that drugs trialled by Semler Research Centre should be suspended.